How many investments has Novalis Biotech made?

Novalis Biotech has 20 tracked investments, including 1 dated in the last 24 months.

What stage does Novalis Biotech invest at?

Novalis Biotech invests at the Pre-Seed, Seed, Series A stages.

Where is Novalis Biotech located?

Novalis Biotech is headquartered in Ghent, BE.

Who does Novalis Biotech co-invest with?

Novalis Biotech most often shares deals with Navigare Ventures, OCCIDENT, Pantera Capital, among 9 tracked co-investors.

Novalis Biotech

Venture capital

Ghent · Pre-Seed–Series A · 7 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Novalis Biotech

3,071 people in our graph share verified history with the Novalis Biotech team — schools, employers, funds. One of them is your warm intro.

Laura Buhlerunlockedknows Kathleen Van den Berghe · together at McKinsey & Company (overlapped)

knows the team · via McKinsey & Company

×3knows the team · via Barclays

knows the team · via INSEAD

×2knows the team · via University of London

knows the team · via Boston Consulting Group

✨ Fox Verdict

Investment thesis

Novalis Biotech invests early in life sciences companies building enabling technologies. It favors capital-light platform technologies and close, early engagement with customers. Priority focus areas include innovative research and manufacturing tools, bioinformatics, genomics, diagnostics, and digital health. The firm targets pre-seed through Series A startups, often coming in at the point of incorporation, and supports their growth by providing funding, sharing professional and academic connections, and helping shape business strategy to create value for all stakeholders.

Invests inAI & Machine Learning Biotech Digital Health FoodTech Healthtech Medical Devices Belgium Europe France Germany Netherlands Portugal Switzerland United States

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Series A

Ghent, BE

Instruments

Equity

Founded

2018

Last 12 months

1 investment

Tracked investments

Team · 7 people

from the firm's website & public directories

Jan Van den Berghe· Founder· Cranbrook, England, United Kingdomin

Jan Van den Berghe co-founded Novalis Biotech Incubation with Wim. An entrepreneur in the food and biotech sectors, he trained as a bio-engineer and previously worked as a senior consultant at the Boston Consulting Group and as an independent strategy consultant. He co-founded and served as director of Genohm, which Agilent Technologies acquired in 2018, and holds an MBA from INSEAD and a Master in General Management from Vlerick Management School.

j•••@noval.isreveal

Wim Van Criekinge· Founder, Novalis Biotech Incubation· Ghent, Belgiumin

Wim Van Criekinge holds a PhD and is a tenured professor of computational genomics and bioinformatics at Ghent University, where he founded and leads the BIOBIX lab and the NXTGNT core sequencing facility. Together with Jan, he co-founded Novalis Biotech Incubation, and he has co-founded biotech startups including Devgen and Genohm. He currently serves as CSO of MDxHealth, a public biotech company focused on uro-oncology, and holds several biotech startup board seats. He earned a Master's in Chemical Engineering and a PhD in Molecular Biology (1998) from the University of Ghent.

w•••@noval.isreveal

Bart Rossel· Scientific Advisor and Advisory Board Member, Novalis Biotech Incubation Fund; Supervisory Board Member of Novalis

Bart Rossel is a bio-engineer by training who has worked in the agro and life science sectors and held several management roles. In 2002, he and his team acquired the pharmaceutical company Oystershell Laboratories, which they sold to Gilde Buy Out Partners in 2017. He holds several patents and authored a book about insects.

Cedric Bogaert· Entrepreneur in Residence· Ghent, Flemish Region, Belgiumin

Cedric Bogaert is an Entrepreneur in Residence at Novalis Biotech, currently managing myNEO. His background includes epigenomic research at UGent and immunovaccine development research at VUB. He previously worked as a pricing architectural lead at Accenture.

Kathleen Van den Berghe· Member of the Supervisory Board· Tervuren, Flemish Region, Belgiumin

Kathleen Van den Berghe serves on the Supervisory Board of Novalis. She has over 20 years of professional experience as a consultant, entrepreneur, employee, and employer across a wide range of industries, with international work on multiple continents. Her stated areas of expertise include strategy and analysis, construction and industry, and wine and tourism.

Liesbeth Ceelen· CEO of BioLizard· Ghent, Flemish Region, Belgiumin

Liesbeth Ceelen holds a PhD in veterinary sciences and began her career at J&J before moving into biotech and healthcare start-ups and scale-ups, where she worked across operations, quality, project management, scientific leadership, sales, and business development. She is currently CEO of BioLizard, a data analytics and data engineering company. She is involved with the Healthcare Businesswomen's Association and the TOPX Network for Women in Life Sciences, and received the Inspiring 50 STEM award in 2022.

Michael Hengartner· Scientific Advisor and Advisory Board Member, Novalis Biotech Incubation Fund· Zurich, Switzerland

Michael Hengartner serves as a Scientific Advisor and Advisory Board Member for the Novalis Biotech Incubation Fund. He is president of the board of ETH in Zurich, Switzerland, and previously served as rector of the University of Zurich from 2014 to 2019. He earned his PhD in 1994 at the Massachusetts Institute of Technology under Nobel Laureate H. Robert Horvitz, led a research group at Cold Spring Harbor Laboratory until 2001, and became a professor of molecular biology at the University of Zurich, where he also served as dean of the Faculty of Science from 2009 to 2014.

Founder mafia

3 people who came through Novalis Biotech went on to found or lead other companies.

Wim Van CriekingeFounder, Novalis Biotech IncubationFounded Lizard +1 Liesbeth CeelenCEO of BioLizardFounded Lizard Cedric BogaertEntrepreneur in ResidenceFounded myNEO Therapeutics

What they invest in

from 18 of 20 portfolio companies

Healthtech ×12Medical Devices ×12Biotech ×10Deep Tech ×9AI & Machine Learning ×6Digital Health ×6Hardware ×2Advanced Manufacturing ×1

HQs:Belgium×4United States×2Switzerland×1Germany×1France×1Netherlands×1

Who they back

founder profiles across 9 portfolio companies

44%

solo founders

4 of 9 mapped founding teams

Founding team size:solo founder×42 founders×33 founders×2

Investments · 20 tracked

founders shown can be your intro path

By year:2026 · 1 2024 · 1 2023 · 1 2022 · 1 2021 · 1 2014 · 16 dated

Trincetrincebio.com in✓ verified

Trince is a Ghent University spin-off developing photoporation technology for physical transfection of cells as an alternative to viral vectors and electroporation.

BiotechDeep TechMedical DevicesGent, BE

Philip

Co-investorsQbic Fund

Alithea Genomicsalitheagenomics.com in 𝕏Mar 2026 · $8.9M

Alithea Genomics develops RNA sequencing technologies and platforms that enable pharmaceutical, agritech, cosmetics, and academic teams to generate large-scale transcriptomic datasets for compound screening, crop engineering, and ingredient development.

AgTechBiotechDeep TechHealthtechLausanne, CH

Riccardo Dainese(CCO and Co-founder)inDaniel Alpern(CSO and Co-founder)in

Co-investorsKickfund

Altavoaltavo.eu

Altavo develops non-invasive silent speech technology using RF sensing and artificial intelligence to help patients who have lost their voice regain natural-sounding speech.

AI & Machine LearningDeep TechMedical DevicesDresden, DE

Rudolf

Co-investorsOCCIDENT

C-mo Medical Solutionsc-mo.solutions inFeb 2023

C-mo develops an automated wearable device that records and analyzes cough patterns in real-time for continuous patient monitoring.

Digital HealthHealthtechMedical DevicesCaparica, PT

Co-investorsBoehringer Ingelheim Venture Fund Portugal Ventures

Carroucellcarroucell.com in

Carroucell develops microcarrier technology for cell and gene therapy applications, enabling cost-effective bioproduction and cell amplification.

BiotechDeep TechMedical DevicesGrenoble, FR

Tarek Fathallah in

Cergentiscergentis.com in

Cergentis is now part of Solvias and provides Targeted Locus Amplification (TLA) technology and genetic characterization services for advanced therapy development.

BiotechDeep TechHealthtechMedical Devices

Clouds of Care NVcloudsofcare.com in

Clouds of Care develops EEG and electrophysiology-based digital health technology and software (including FDA-cleared/CE-marked SaMD) to provide meaningful endpoints for clinical development in CNS disorders such as epilepsy and sleep disorders.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Co-investorsPMV White Fund

Docdoc.ai

HealthtechBoise, US

Walter De Brouwer(Executive Officer, Director)Hassinger David(Executive Officer)Ming-Wai Chung(Executive Officer)Alan Greene(Executive Officer)

Co-investorsComet Labs Pantera Capital

Enzyreenzyre.comNov 2022

Enzyre develops a handheld diagnostic device that performs multiple blood coagulation assays in parallel to identify bleeding causes at the point of care.

BiotechDeep TechDigital HealthHealthtechMedical DevicesEindhoven, NL

Wim van den Broek(CEO)inWaander(CSO)

Co-investorsi&i Biotech Fund Oost NL Takeda Ventures

Fertigafertiga.com in

Fertiga is a biotech company that develops diagnostic tools to improve IVF success rates.

BiotechDigital HealthFemTechHealthtechMedical DevicesBrussels, BE

Prof. Dr. Johan Smitz(Co-founder & Chief Medical Officer)Ir. Elien Van Hecke(Co-founder & Chief Executive Officer)Prof. Dr. André Rosenthal(Co-founder & Board member)

Graphealgrapheal.com inFeb 2021

Grapheal develops graphene-based biosensors, including PFAST, a field-deployable device for fast, real-time detection of ultra-trace PFAS ("forever chemicals") in water.

CleantechDeep TechHardware

Co-investorsBpifrance EIC

Lizardlizard.bio in

BioLizard provides analytics and AI solutions to convert complex biomedical data into actionable insights for pharmaceutical and biotech companies across discovery and clinical development phases.

AI & Machine LearningBiotechData & InfrastructureHealthtech

Modalitymodality.ai

Modality.AI develops an AI-based multimodal assessment platform that uses app-collected data to help diagnose and monitor neurodegenerative diseases such as ALS.

AI & Machine LearningDigital HealthHealthtechMedical Devices

David Suendermann-Oeft(Co-founder & CEO)in David Pautler(Co-founder & CTO)in

Co-investorsCARELA Holding GmbH Lair East Labs

myNEO Therapeuticsmyneotx.com in

myNEO provides AI-powered software for drug discovery and development, specifically targeting antibody, bispecific, ADC, cell therapy, vaccine, and neoantigen-based immunotherapy programs.

AI & Machine LearningBiotechHealthtechSaaS

Board Cedric Bogaert in Jan Van Den Berghe in Wim van Criekinge in

Ohmxohmx.bio inOct 2014

Evanston, US

Thomas Meade(Director)CHARLES PENNINGTON(CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD OF ISSUER)

BoardBrian Dyson(Director)Barbara Beug Dyson(Director)Peter L. Dyson(Director)Scott Hall(Director)

Peggypeggy.com 𝕏

Peggy is a social marketplace app for buying, selling, and discovering contemporary art, serving artists, galleries, and collectors.

ConsumerE-commerceFintechMarketplacesMedia & Entertainment

Adam Meghji(Co-Founder)in Craig Follett(Co-Founder & CEO)in

Co-investorsBackbone Angels Entrepreneur Ventures Garage Capital Z Venture Capital Nomad Capital

Rarity Bioscienceraritybioscience.com inJun 2024

Rarity Bioscience develops superRCA, a molecular detection technology that identifies DNA mutations with exceptional sensitivity for precision medicine applications.

BiotechDeep TechDigital HealthHealthtechMedical DevicesUppsala, SE

Lei Chen(Co-Founder & CTO)inUlf Landegren(Co-Founder & Board Member)Per Matsson(Co-Founder & Chairman of the Board)in

Co-investorsNavigare Ventures

Rheavitarheavita.com in

RheaVita manufactures scalable freeze-dryer systems for pharmaceutical and vaccine development, ranging from R&D models to GMP-compliant production units.

Advanced ManufacturingBiotechDeep TechHardwareMedical DevicesGhent, BE

Jos Corver(Co-founder)in Thomas De Beer(CEO)in

Co-investorsPMV

RheumaFinderrheumafinder.ai in

RheumaFinder is an AI-powered application that analyzes CT images to detect structural bone lesions in the sacroiliac joints, intended to support radiologists in identifying patients with rheumatic disease.

AI & Machine LearningHealthtechMedical Devices

Nicolaas Fosselle(Founder)in

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

H42 Inc

Portfolio news

latest coverage across their companies

Peggy Flanagan vows to 'rip ICE apart' after toppling moderate Dem in key Senate battle

Peggy · foxnews.com · Aug 12, 2026

Grapheal Raises €2.5M in Grant from EIC

Grapheal · finsmes.com · Jun 8, 2026

Ingenix raises €13M led by Sofinnova to scale Modality Fusion AI — Sofinnova Partners

Modality · sofinnovapartners.com · Jun 3, 2026

Dutch Company Raises Over $12 Million for Development of Home-based Blood Coagulation Test | Managed Healthcare Executive

Enzyre · managedhealthcareexecutive.com · May 7, 2026

C-mo Medical Solutions Receives CE Mark for Its Novel AI-Powered Cough Monitoring Solution - BioSpace

C-mo Medical Solutions · biospace.com · Apr 15, 2026

Alithea Genomics raises CHF 6.9M to industrialize RNA sequencing

Alithea Genomics · ggba.swiss · Mar 9, 2026

Altavo Closes €3M Series A2 Financing Round

Altavo · finsmes.com · Jan 23, 2026

Trince raises €5,2 million ($6 million) funding to fuel commercial expansion and technology development.

Trince · natlawreview.com · Jan 22, 2026

Frequently asked questions

How many investments has Novalis Biotech made?: Novalis Biotech has 20 tracked investments, including 1 dated in the last 24 months.
What stage does Novalis Biotech invest at?: Novalis Biotech invests at the Pre-Seed, Seed, Series A stages.
What sectors does Novalis Biotech focus on?: Novalis Biotech focuses on AI & Machine Learning, Biotech, Digital Health, FoodTech, Healthtech, Medical Devices.
Where is Novalis Biotech located?: Novalis Biotech is headquartered in Ghent, BE.
Who does Novalis Biotech co-invest with?: Novalis Biotech most often shares deals with Navigare Ventures, OCCIDENT, Pantera Capital, among 9 tracked co-investors.

Images

Similar investors

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Overwater Ventures Llc

Overwater Ventures is an early-stage venture firm that partners with pre-seed and seed stage founders working on large-scale problems, offering hands-on support across launch strategy, go-to-market, fundraising, and marketing.

$400K – $2M

Rockies Venture Club

Rockies Venture Club is an angel investor network of 100+ active members focused on Seed to Series A opportunities, offering due diligence, syndication nationwide, and educational programming for investors and entrepreneurs.

$100K – $500K

MPG Fund

MPG Fund is an early-stage venture investor backing technology startups.

VTC Ventures

VTC Ventures is an early-stage venture fund managed by Middleland Capital and backed by strategic LPs including Virginia Tech, the Fralin Biomedical Research Institute, and Carilion Clinic. It invests in healthcare, deep tech/defense/AI, and food & agriculture, offering founders access to clinical, research, and commercialization resources.

$100K – $5M